TY - JOUR
T1 - Disorders of orgasm and ejaculation in men
AU - Rowland, David
AU - McMahon, Chris G.
AU - Abdo, Carmita
AU - Chen, Juza
AU - Jannini, Emmanuele
AU - Waldinger, Marcel D.
AU - Ahn, Tai Young
N1 - Funding Information:
Conflict of Interest: Rowland: None; McMahon: Paid consultant, advisory board member and/or speaker for Janssen Cilag, Plethora UK, Bayer Schering; Abdo—participate in clinical trials sponsored by Eli Lilly, Pfizer and Janssen-Cilag; Member of Advisory Board and speaker of Eli Lilly, Pfizer, Janssen-Cilag; Chen: None; Jannini-Johnson and Johnson—Consultant and paid speaker; Pfizer—Consultant, paid speaker, grant recipient; Waldinger—none; Ahn—none.
PY - 2010/4
Y1 - 2010/4
N2 - Introduction. Ejaculatory/orgasmic disorders are common male sexual dysfunctions, and include premature ejaculation (PE), inhibited ejaculation, anejaculation, retrograde ejaculation, and anorgasmia. Aim. To provide recommendations and guidelines concerning current state-of-the-art knowledge for management of ejaculation/orgasmic disorders in men. Methods. An international consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 25 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge of disorders of orgasm and ejaculation represent the opinion of seven experts from seven countries developed in a process over a 2-year period. Main Outcome Measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. Premature ejaculation management is largely dependent upon etiology. Lifelong PE is best managed with PE pharmacotherapy (selective serotonin re-uptake inhibitor [SSRI] and/or topical anesthetics). The management of acquired PE is etiology specific and may include erectile dysfunction (ED) pharmacotherapy in men with comorbid ED. Behavioral therapy is indicated when psychogenic or relationship factors are present and is often best combined with PE pharmacotherapy in an integrated treatment program. Retrograde ejaculation is managed by education, patient reassurance, pharmacotherapy, or bladder neck reconstruction. Delayed ejaculation, anejaculation, and/or anorgasmia may have a biogenic and/or psychogenic atiology. Men with age-related penile hypoanesthesia should be educated, reassured, and instructed in revised sexual techniques which maximize arousal. Conclusions. Additional research is required to further the understanding of the disorders of ejaculation and orgasm. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, and Ahn TY. Disorders of Orgasm and Ejaculation in Men.
AB - Introduction. Ejaculatory/orgasmic disorders are common male sexual dysfunctions, and include premature ejaculation (PE), inhibited ejaculation, anejaculation, retrograde ejaculation, and anorgasmia. Aim. To provide recommendations and guidelines concerning current state-of-the-art knowledge for management of ejaculation/orgasmic disorders in men. Methods. An international consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 25 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge of disorders of orgasm and ejaculation represent the opinion of seven experts from seven countries developed in a process over a 2-year period. Main Outcome Measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. Premature ejaculation management is largely dependent upon etiology. Lifelong PE is best managed with PE pharmacotherapy (selective serotonin re-uptake inhibitor [SSRI] and/or topical anesthetics). The management of acquired PE is etiology specific and may include erectile dysfunction (ED) pharmacotherapy in men with comorbid ED. Behavioral therapy is indicated when psychogenic or relationship factors are present and is often best combined with PE pharmacotherapy in an integrated treatment program. Retrograde ejaculation is managed by education, patient reassurance, pharmacotherapy, or bladder neck reconstruction. Delayed ejaculation, anejaculation, and/or anorgasmia may have a biogenic and/or psychogenic atiology. Men with age-related penile hypoanesthesia should be educated, reassured, and instructed in revised sexual techniques which maximize arousal. Conclusions. Additional research is required to further the understanding of the disorders of ejaculation and orgasm. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, and Ahn TY. Disorders of Orgasm and Ejaculation in Men.
KW - Anejaculation
KW - Behavioral Therapy
KW - Ejaculation
KW - Inhibited Ejaculation
KW - Premature Ejaculation
KW - Psychotherapy
KW - Retrograde Ejaculation
KW - Selective Serotonon Re-Uptake Inhibitors
KW - Topical Anesthetics
UR - https://www.scopus.com/pages/publications/77955234560
U2 - 10.1111/j.1743-6109.2010.01782.x
DO - 10.1111/j.1743-6109.2010.01782.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:77955234560
SN - 1743-6095
VL - 7
SP - 1668
EP - 1686
JO - Journal of Sexual Medicine
JF - Journal of Sexual Medicine
IS - 4 PART 2
ER -